Adil Daud

Interested in all kinds of things

[Siraj Master @sirajmaster02]

🎊🎊Happy New Year 🎊🎊 May we all have a bright 2023 ahead 💐 @ UAE Sharjah https://t.co/RsbXYqwqJP

[Erika Hamilton, MD, FASCO @ErikaHamilton9]

Four decades of clinical trials: 14.2 million life-years gained, at $326 per year https://t.co/7aE7PlZ0Bu

[Journal for ImmunoTherapy of Cancer @jitcancer]

Countdown to 2023: #JITCTop10 - Assessment of hyperprogression versus the natural course of disease development with nivolumab with or without ipilimumab versus placebo in phase III, randomized, controlled trials https://t.co/oFgMSYp6B8 @MartinReck2 @PaulNghiem

[Adil Daud @AdilDaud3]

Monumental work @jvincentchan @alexis_combes @MaxKrummel @UCSFCancer !! Map of cancer immune archetypes expands, deepens and adds dimension to the(useful) “hot” and “cold” classification

[Vincent Chan @jvincentchan]

Congrats @alexis_combes 🎉. Happy to see this out in @CellCellPress after 6 years of hard work!

[CrozrX @CrozrX]

@alexshoushtari @jasonlukemd @DrSapnaPatel @MelanomaReAlli @amenzies9 @DrBetofMDPhD @AdilDaud3 @ragikudchadkar @PAscierto @CureMelanoma @Immunocore @UPMCHillmanCC @HTawbi_MD More good news for #Uvealmelanoma #UM MAPK /FAKi combo study.
https://t.co/2aCRYwPUR2
And recent @AACR journal article covering the same topic! This combination approach also decreased the tumor burden in models of uveal melanoma liver metastasis.

[Adil Daud @AdilDaud3]

Thanks @coughlin582 ! Adding a paper from James Lee and @kickassscience1 declining into the mechanism https://t.co/nGgNfMRb1x

[Christina Coughlin @coughlin582]

Liver - unfriendly place for IO therapy. First described by @AdilDaud3 More on mech here.
https://t.co/JR4ZJTddyk
https://t.co/v45ouqLyQF

[Christina Coughlin @coughlin582]

Liver - unfriendly place for IO therapy. First described by @AdilDaud3 More on mech here.
https://t.co/JR4ZJTddyk
https://t.co/v45ouqLyQF

[Christopher Garris @csgarrix]

I wrote a review with @jasonlukemd highlighting the responses of #dendriticcells (DC) in cancer @CCR_AACR. We are now beginning to understand critical roles DCs in tumors play in coordinating anti-tumor immune responses.
https://t.co/rfStkGIGwM

[Katy Tsai, MD @katyktsai]

This!! As a new mom who has been back at academic oncology now for 2 months (sorry I've been slacking on my social media😝)- this is amazing. Any more detail on childcare location @ASCO ? Also PSA for BFing mamas: dl @MAMAVA app, so helpful! #career #mom #ichooseboth

[Elad Sharon @EladSharonMD]

Have a patient with an #EndocrineSideEffect as a result of an #immunotherapy? A nice review of the topic is available here: https://t.co/vwE0gvlyG4 Authors from @MSKCC_OncoNotes, @theNCI, @LombardiCancer, @DanaFarber, @WeillCornell & others! Coordinated by @NCICTEP_ClinRes!

[Dr. Ravi Wankhede @DrAltruism]

Dhanyawad Rashtrapatiji. Ye shayad peheli baar aisa nyota kisi Rashtrapati ne diya hoga. Mujhe aur mere pariwar ko Maji Rashtrapati Smt. Pratibhatai Patil ne amantrit kiya tha 2010 me. Iska kaaran maine ek dost ko apni kidney daan ki thi. Mera dost muslim tha. Dhanyawad.

[Anirban Maitra @Aiims1742]

THREE papers in @NatureMedicine on the unexpected role of Shp2 inhibition in KRAS mutant #LungCancer #PancreaticCancer #GastricCancer
- Shp2inh also bypasses the well known resistance mechanisms to MEKinh
https://t.co/IwJ2JNJ1h8
https://t.co/wwZTL3rvnh
https://t.co/aexStYkvup

[Anirban Maitra @Aiims1742]

Therapeutic developments in #PancreaticCancer: current and future perspectives
https://t.co/H50TXqFiQU
I like Figure 1 (I hate the actual survival numbers but it's a succinct reminder of where we stand)
Also the #immunotherapy portion is a mini-review by itself
@NatRevGastroHep

[K @HollevoetKevin]

🏆 🏆 🏆 https://t.co/sw4tBmqxM5

[Rich Joseph @RichardWJoseph]

I had a lot of fun working with @PD_value on this analysis. It only took us 4 years from concept to publication! https://t.co/n23gOIAg1c

[Adil Daud @AdilDaud3]

Looking forward to an interview session! @zanubiatshams @GururajRai @tahershams - future of health care in the Middle East https://t.co/D8tazjVQME

[فوربس الشرق الأوسط @ForbesME]

Join us on March 31, 2018 as Forbes Middle East gathers industry leaders and regulators from the healthcare industry to examine some of the pressing challenges plaguing healthcare.
#forbesmehealth #healthcare #innovation #investment #Middleeast #forbesme
https://t.co/ZHFywYjT1N

[Taher Shams @tahershams]

We are thankful to @Drrashidalleem and all delegates for joining us in launching this year's colon #cancer awareness initiative offering #free screenings to our communities in UAE. #ScreenAndSurvive @DHA_Dubai

[Adil Daud @AdilDaud3]

Excited to kick off colorectal cancer screening campaign @zulekhahosptls. #ColorectalCancer affects women as well as men, is highly curable if detected early and has simple, safe, effective screening tests. https://t.co/Dpd971lm9U

[Taher Shams @tahershams]

If you are forty and you know it, screen your colon!

[K @HollevoetKevin]

Excited for next week's IO @marketsmarkets meeting, London https://t.co/onfz3ArKZk. Gene-based #immunotherapy well represented by $ONCS (DNA), #CureVac (mRNA), @Psioxus (oncolytic), and our #antibodygenetransfer program @LeuvenU. Belgian biotechs presenting: $ABLX $CYAD #iTeos